Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Honglei Yuan
PI3K Inhibitor Treatment Ameliorates the Glucocorticoid Insensitivity of PBMCs in Severe Asthma
Clinical and Translational Medicine
Medicine
Molecular Medicine
Related publications
Benralizumab for the Treatment of Severe Eosinophilic Asthma
Prescriber
Pharmacology
Dupilumab Efficacy and Safety in Moderate-To-Severe Uncontrolled AsthmaEfficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Pediatrics
Child Health
Pediatrics
Perinatology
Benralizumab: A Unique IL-5 Inhibitor for Severe Asthma
Journal of Asthma and Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
Oxygen Treatment for Acute Severe Asthma
BMJ
Prm50 - Improvement of Efficiency of Severe Atopic Asthma Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Biological Treatment of Severe Asthma: New Objectives and New Treatment Options
Medical Council
Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?
European Clinical Respiratory Journal
PI3K Inhibitor–Induced Insulin Feedback Activates PI3K Signaling
Cancer Discovery
Oncology
Benralizumab in the Treatment of Severe Asthma: Design, Development and Potential Place in Therapy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science